On Monday, November 16, 2020, the Company, Arbutus Biopharma Corporation, ABUS stock construct a change of 0 percent (Remain Flat) in a total of its share price and having its trading value $3.63, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $301.40M with the total Outstanding Shares of 79.49M.
P/S, P/E, P/B & P/C values of (NASDAQ: ABUS):
Arbutus Biopharma Corporation institutional ownership is standing at 30.5 percent, while insider ownership is 1.6 percent. As of now, ABUS has a P/S, P/E and, P/B values of 49.41, 0, and 0 respectively. Its P/Cash is valued at 2.55.
The stock SMA50 is now at 21.46 percent. In looking, the SMA 200 we see that the stock has seen a 44.93 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.
Profitability ratios:
Looking into the profitability ratios of ABUS stock, an investor will find its ROE, ROA, ROI standing at 128.9 percent, -76.2 percent and, 203.2 percent, respectively.
Beta Factor:
A beta factor is used to measure the volatility of the stock. The stock remaining at 10.5 percent volatile for the week and 7.35 percent for the month.
Gross / Operating Margins of ABUS:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.
Target Price:
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Arbutus Biopharma Corporation recorded it at $6.
Historical Performance In The News:
Taking a look at the performance of Arbutus Biopharma Corporation stock, an investor will come to know that the weekly performance for this stock is valuing at 14.15 percent, resulting in a performance for the month at 18.24 percent.
Therefore, the stated figure displays a quarterly performance of 5.22 percent, bringing six-month performance to 57.14 percent and year to date performance of 30.58 percent. As of now, Arbutus Biopharma Corporation has a P/S, P/E and, P/B values of 49.41, 0, and 0 respectively. Its P/Cash is valued at 2.55.
Earnings per Share Details of Arbutus Biopharma Corporation:
The EPS of ABUS is strolling at -1.24, measuring its EPS growth this year at -137.8 percent. As a result, the company has an EPS growth of 17.3 percent for the approaching year.
